Investor Relations
Investor Relations

Investor Relations
Investor Relations

Instagram

You Tube

HOME > Investor Relations > IR News

IR News

2021

IR 2021/04/16

Notice regarding acquisition of a distribution center by our Consolidated Subsidiary
IR 2021/03/29

Notice regarding organizational changes and personnel changes
IR 2021/03/29

Notice regarding personnel changes
IR 2021/03/23

Notice regarding acquisition and acquisition completion of Treasury Stock
IR 2021/03/22

Notice regarding acquisition of Treasury Stock
IR 2021/03/10

Notice regarding acquisition of Treasury Stock
IR 2021/02/10

Notice regarding acquisition of Treasury Stock
IR 2021/02/05

Notice regarding revision of full year earnings forecast for the fiscal year ending March 2021
IR 2021/02/05

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2021
IR 2021/02/05

Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2021
IR 2021/01/08

Notice regarding acquisition of Treasury Stock

2020

IR 2020/12/21

Notice regarding personnel changes
IR 2020/12/21

Notice regarding organizational changes and personnel changes
IR 2020/12/10

Notice regarding acquisition of Treasury Stock
IR 2020/12/01

Notice regarding changes in the duties of directors
IR 2020/12/01

Notice regarding acquisition of Treasury Stock
IR 2020/12/01

Notice regarding organizational changes and personnel changes
IR 2020/11/06

Notice regarding conclusion of contract with Gene Therapy Research Institution Co., Ltd. to manufacture gene therapy products
IR 2020/11/06

Notice regarding revision of full year earnings forecast for the fiscal year ending March 2021
IR 2020/11/06

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31,2021
IR 2020/11/06

Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2021
IR 2020/10/16

Notice regarding conclusion of comprehensive partnership agreement with Cyfuse Biomedical K.K to manufacture cell products
IR 2020/10/09

Notice regarding establishment of Corporate Venture Fund
IR 2020/09/28

Notice regarding revision of the first half and full year earnings forecast for the fiscal year ending March 2021
IR 2020/08/31

Annual Securities Report for the 74rd business term (April 1, 2019 to March 31, 2020)
IR 2020/08/31

Notice regarding acquisition of Treasury Stock
IR 2020/08/21

Results Briefing Material for Financial Results fir the First Quarterof the Fiscal Year Ending March 31,2021
IR 2020/08/21

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2021
IR 2020/08/13

Notice regarding acquisition of Treasury Stock
IR 2020/08/13

Notification of the Borrowing of Funds
IR 2020/08/06

Notice of Partial correction to “Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 “
IR 2020/07/13

Notice regarding Business Transfer and Establishment of a New Subsidiary under our Consolidated Subsidiary
IR 2020/06/15

Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2020
IR 2020/06/11

Consolidated Financial Results for the Fiscal Year Ended March 31,2020
IR 2020/05/28

NOTICE OF 74RD ORDINARY GENERAL SHAREHOLDERS’ MEETING
IR 2020/02/19

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31,2020
IR 2020/02/19

Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2020

2019

IR 2019/12/12

Annual Report 2019
IR 2019/11/18

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31,2020
IR 2019/11/14

Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2020
IR 2019/11/05

Notification of the Borrowing of Funds　
IR 2019/11/05

Notification of the Completion of the Acquisition of New Company Shares and Ownership of the Takatsuki Plant of Daiichi Sankyo Propharma Co., Ltd. (Subsidiary Acquisition)
IR 2019/08/20

Results Briefing Material for Financial Results fir the First Quarterof the Fiscal Year Ending March 31,2020
IR 2019/08/20

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2020
IR 2019/08/20

Annual Securities Report for the 73rd business term (April 1, 2018 to March 31, 2019)
IR 2019/06/14

Results Briefing Material for Financial Results for the Fiscal Year Ended March 31,2019
IR 2019/06/04

Notification of the Acquisition of a Long-listed Product
IR 2019/06/04

Consolidated Financia Results for the Fiscal Year Ended March 31,2019
IR 2019/05/30

NOTICE OF 73RD ORDINARY GENERAL SHAREHOLDERS’ MEETING
IR 2019/03/25

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2019
IR 2019/03/25

Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019
IR 2019/03/25

Notice of Capital and Business Alliance with Cyfuse Biomedical K.K.
IR 2019/03/22

Notice of Investment with Wingo Technology Co.,Ltd.
IR 2019/02/14

Concerning acquisition of new company shares and ownership of Daiichi Sankyo Propharma Co., Ltd. Takatsuki Plant (subsidiary acquisition)
IR 2019/01/08

Completion of Transfer of Marketing and Manufacturing Rights of 13 Long-Term Listed Products from Chugai to Taiyo Pharma

2018

IR 2018/12/04

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2019
IR 2018/11/29

Annual Report 2018
IR 2018/11/29

Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2019
IR 2018/09/05

Annual Securities Report for the 72nd business term (April 1, 2017 to March 31, 2018)
IR 2018/08/31

Shared Research Report has been updated (Q1 FY03/19)
IR 2018/08/16

Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2019
IR 2018/08/16

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2019
IR 2018/08/08

Shared Research Flash Report has been updated (Q1 FY03/19 Flash Update)
IR 2018/06/26

Shared Research Flash Report has been updated (Revision to FY03/18 Results and New Segment Information)
IR 2018/06/05

NOTICE OF 72ND ORDINARY GENERAL SHAREHOLDERS’ MEETING
IR 2018/05/30

Shared Research Report has been updated (Full-year FY03/18)
IR 2018/05/22

Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2018
IR 2018/05/22

Consolidated Financial Results for the Fiscal Year Ended March 31, 2018
IR 2018/03/30

Shared Research Report has been updated (concerning Notice of Revision to Dividend Forecast and A Plan to Buy Back Shares)
IR 2018/02/14

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2018
IR 2018/02/14

Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018
IR 2018/01/05

Notice Concerning Execution of Asset Transfer of 13 Long-Term Listed Products from Chugai to Taiyo Pharma

2017

IR 2017/11/28

Annual Report 2017 (revised)
IR 2017/11/28

Notice Regarding Correction to Taiyo Holdings’ Annual Report 2017
IR 2017/11/20

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2018
IR 2017/11/20

Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2018
IR 2017/11/14

Marketing and Manufacturing Right Transfer of 13 Long-Term Listed Products from Chugai to Taiyo Pharma
IR 2017/11/14

Marketing and Manufacturing Rights Transfer of 13 Long-Term Listed Products
IR 2017/08/09

Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2018
IR 2017/08/09

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2018
IR 2017/06/15

NOTICE OF 71ST ORDINARY GENERAL SHAREHOLDERS’ MEETING
IR 2017/06/14

Notice Concerning Formulation of Medium-Term Business Plan
IR 2017/05/22

Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2017
IR 2017/05/22

Consolidated Financial Results for the Fiscal Year Ended March 31, 2017
IR 2017/02/07

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2017
IR 2017/02/07

Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2017
IR 2017/02/02

Notice Concerning a Capital and Business Alliance with DIC Corporation, Issuance of New Shares through a Third-party Allotment, Disposition of Treasury Shares, and Changes in Major Shareholders, the Top Shareholder among Major Shareholders, and Associated Companies.

2016

IR 2016/11/11

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2017
IR 2016/11/11

Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2017
IR 2016/11/02

Annual Report 2016
IR 2016/08/10

Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2017
IR 2016/08/10

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2017
IR 2016/05/17

Consolidated Financial Results for the Fiscal Year Ending March 31, 2016
IR 2016/05/17

Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2016
IR 2016/02/09

Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2016
IR 2016/02/09

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2016

2015

IR 2015/12/22

Annual Report 2015
IR 2015/11/11

Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2016
IR 2015/11/11

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016
IR 2015/08/07

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2016
IR 2015/08/07

Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2016
IR 2015/05/21

Consolidated Financial Results for the Fiscal Year Ending March 31, 2015
IR 2015/05/21

Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2015
IR 2015/02/09

Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2015
IR 2015/02/09

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2015

2014

IR 2014/11/17

Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2015
IR 2014/11/17

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2015
IR 2014/10/17

Annual Report 2014
IR 2014/08/20

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2015
IR 2014/08/20

Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2015
IR 2014/05/22

Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2014
IR 2014/05/22

Consolidated Financial Results for the Fiscal Year Ending March 31, 2014
IR 2014/02/17

Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2014
IR 2014/02/17

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2014

2013

IR 2013/12/06

Annual Report 2013
IR 2013/11/26

Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2014
IR 2013/11/26

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2014
IR 2013/08/27

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2014
IR 2013/08/27

Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2014
IR 2013/05/27

Consolidated Financial Results for the Fiscal Year Ending March 31, 2013
IR 2013/05/27

Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2013
IR 2013/02/19

Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2013
IR 2013/02/14

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2013

2012

IR 2012/11/22

Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2013
IR 2012/11/22

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2013
IR 2012/10/19

Annual Report 2012
IR 2012/08/09

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2013
IR 2012/08/09

Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2013
IR 2012/05/30

Consolidated Financial Results for the Fiscal Year Ending March 31, 2012
IR 2012/05/30

Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2012
IR 2012/02/17

Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2012
IR 2012/02/17

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2012

2011

IR 2011/11/22

Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2012
IR 2011/11/17

Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2012
IR 2011/09/09

Annual Report 2011
IR 2011/09/01

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2012
IR 2011/08/09

Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2012
IR 2011/05/30

Consolidated Financial Results for the Fiscal Year Ended March 31, 2011
IR 2011/05/30

Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2011
IR 2011/02/18

Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2011
IR 2011/02/18

Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2011

2010

2009

2008

Investor Relations
Investor Relations